These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25038235)

  • 1. Paying attention to the preciseness of conclusion.
    Yuan K; Chen J; Li T; Xu A
    Ann Rheum Dis; 2014 Nov; 73(11):e66. PubMed ID: 25038235
    [No Abstract]   [Full Text] [Related]  

  • 2. The TRIFRA trial: efforts employed to minimise expectation bias.
    Lv QW; Zhang W; Shi Q; Zheng WJ; Lipsky PE; Zhang X
    Ann Rheum Dis; 2014 Nov; 73(11):e67. PubMed ID: 25057182
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: 'comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial' by Qian-wen et al.
    Landewé RB; van der Heijde D
    Ann Rheum Dis; 2014 Oct; 73(10):e62. PubMed ID: 25013090
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of rheumatoid arthritis.
    Marcus DM
    Ann Rheum Dis; 2014 Sep; 73(9):e56. PubMed ID: 24938284
    [No Abstract]   [Full Text] [Related]  

  • 5. The safety and effectiveness of a chloroform/methanol extract of Tripterygium wilfordii Hook F (T2) plus methotrexate in treating rheumatoid arthritis.
    Zhang W; Shi Q; Zhao LD; Li Y; Tang FL; Zhang FC; Zhang X
    J Clin Rheumatol; 2010 Dec; 16(8):375-8. PubMed ID: 21085018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis.
    Wang X; Zu Y; Huang L; Yu J; Zhao H; Wen C; Chen Z; Xu Z
    Life Sci; 2017 Feb; 171():45-50. PubMed ID: 28088452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TwHF versus methotrexate in the treatment of rheumatoid arthritis: response to Landewe's comment on the TRIFRA study.
    Lv QW; Chen T; Zhang W; Shi Q; Zheng WJ; Lipsky PE; Zhang X
    Ann Rheum Dis; 2014 Oct; 73(10):e63. PubMed ID: 25063826
    [No Abstract]   [Full Text] [Related]  

  • 8. 2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis.
    Zhang X; Xia J; Jiang Y; Pisetsky DS; Smolen JS; Mu R; Dai S; Weinblatt ME; Kvien TK; Li J; Dörner T; Zhang Y; Lu L; Yang C; Yang P; Zhang Y; Xu C; Zhao Z; Lipsky PE
    J Autoimmun; 2024 Jan; 142():103148. PubMed ID: 37967495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Chinese herbal remedy Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis.
    Ann Intern Med; 2009 Aug; 151(4):I-36. PubMed ID: 19687475
    [No Abstract]   [Full Text] [Related]  

  • 10. New drugs for rheumatoid arthritis.
    Roberts LJ
    N Engl J Med; 2004 Dec; 351(25):2659-61; author reply 2659-61. PubMed ID: 15602032
    [No Abstract]   [Full Text] [Related]  

  • 11. Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard?
    Boers M
    Arthritis Rheum; 2003 Jun; 48(6):1481-3. PubMed ID: 12794813
    [No Abstract]   [Full Text] [Related]  

  • 12. New drugs for rheumatoid arthritis.
    Messori A; Santarlasci B; Vaiani M
    N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of rheumatoid arthritis with adalimumab. Results from a Cochrane review].
    Pedersen SJ; Hetland ML; Østergaard M
    Ugeskr Laeger; 2006 Aug; 168(35):2899-903. PubMed ID: 16982019
    [No Abstract]   [Full Text] [Related]  

  • 14. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.
    Wolfe F; Caplan L; Michaud K
    J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626
    [No Abstract]   [Full Text] [Related]  

  • 15. A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis.
    Canter PH; Lee HS; Ernst E
    Phytomedicine; 2006 May; 13(5):371-7. PubMed ID: 16487688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate treatment and mortality in rheumatoid arthritis.
    Slot O
    Lancet; 2002 Oct; 360(9339):1095; author reply 1097-8. PubMed ID: 12384008
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate treatment and mortality in rheumatoid arthritis.
    Tröger U; Bode-Böger SM
    Lancet; 2002 Oct; 360(9339):1096; author reply 1097-8. PubMed ID: 12384010
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to D.M. Marcus's comment on the TRIFRA study (comparison of Tripterygium wilfordii Hook F vs methotrexate in the treatment of active rheumatoid arthritis).
    Lv QW; Zhang W; Shi Q; Zheng WJ; Lipsky PE; Zhang X
    Ann Rheum Dis; 2014 Sep; 73(9):e57. PubMed ID: 25085980
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate use in rheumatoid arthritis.
    O'Dell JR
    Rheum Dis Clin North Am; 1997 Nov; 23(4):779-96. PubMed ID: 9361155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trial.
    Fleischmann R; Kavanaugh A; Smolen J
    Rheumatology (Oxford); 2013 Mar; 52(3):409-10. PubMed ID: 23070312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.